Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125683821 | 12568382 | 1 | I | 2013 | 20160706 | 20160718 | 20160718 | PER | US-ASTRAZENECA-2016SE73974 | ASTRAZENECA | 78.00 | YR | F | Y | 39.00000 | KG | 20160719 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125683821 | 12568382 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | CAPSULE | QD | |||||||
| 125683821 | 12568382 | 2 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125683821 | 12568382 | 1 | Gastrooesophageal reflux disease |
| 125683821 | 12568382 | 2 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125683821 | 12568382 | Body height decreased | |
| 125683821 | 12568382 | Dysphagia | |
| 125683821 | 12568382 | Erosive oesophagitis | |
| 125683821 | 12568382 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125683821 | 12568382 | 1 | 2001 | 0 | ||
| 125683821 | 12568382 | 2 | 2001 | 0 |